摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3'-O-<4''-((N-dansyl)-5'''-aminopent-1-yl-oxy)-5''-methoxy-2''nitrophenylmethyl>-2'-deoxy-5'-O-(tert-butyldiphenylsilyl)-N-6-benzoyladenosine | 221895-92-7

中文名称
——
中文别名
——
英文名称
3'-O-<4''-((N-dansyl)-5'''-aminopent-1-yl-oxy)-5''-methoxy-2''nitrophenylmethyl>-2'-deoxy-5'-O-(tert-butyldiphenylsilyl)-N-6-benzoyladenosine
英文别名
——
3'-O-<4''-((N-dansyl)-5'''-aminopent-1-yl-oxy)-5''-methoxy-2''nitrophenylmethyl>-2'-deoxy-5'-O-(tert-butyldiphenylsilyl)-N-6-benzoyladenosine化学式
CAS
221895-92-7
化学式
C58H64N8O10SSi
mdl
——
分子量
1093.35
InChiKey
ITSQRUORFLFZHZ-CCCGGDKUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    9.19
  • 重原子数:
    78.0
  • 可旋转键数:
    23.0
  • 环数:
    9.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    211.4
  • 氢给体数:
    2.0
  • 氢受体数:
    15.0

反应信息

  • 作为反应物:
    描述:
    3'-O-<4''-((N-dansyl)-5'''-aminopent-1-yl-oxy)-5''-methoxy-2''nitrophenylmethyl>-2'-deoxy-5'-O-(tert-butyldiphenylsilyl)-N-6-benzoyladenosine四丁基氟化铵 作用下, 以 四氢呋喃 为溶剂, 反应 0.75h, 生成 3'-O-<4''-((N-dansyl)-5'''-aminopent-1-yl-oxy)-5''-methoxy-2''nitrophenylmethyl>-2'-deoxy-N-6-benzoyladenosine 5'-O-triphosphate
    参考文献:
    名称:
    Syntheses of Nucleosides Designed for Combinatorial DNA Sequencing
    摘要:
    Nucleoside triphosphates I with 3'-O-blocking groups that are both photolabile and fluorescent were required to investigate the viability of a strategy for sequencing DNA in a combinatorial fashion (see Figure 1). Four compounds were prepared to realize this goal. Two of them, 14a and 14t, had dansyl-functionalized, 3'-O-(2"-nitrobenzyl) ether groups, while the other two, 18a and 18t, had similar pendant carbonate groups. Tests for incorporation of these analogues were performed by using five different DNA replicating enzymes, but the analogues were not incorporated. These results were surprising in view of the fact that previous studies had shown that 3'-O-(2"-nitrobenzyl)adenosine triphosphate II was incorporated by Bst DNA polymerase I. However, molecular simulations with the coordinates of a T7 polymerase crystal structure as a model demonstrates that analogues 14a, 14t, 18a and 18t are too large to fit into the enzyme active site, whereas accommodation of the unsubstituted 2-nitrobenzyl compound II is much less demanding. We conclude that both the nucleoside triphosphates and the DNA polymerase enzyme must be modified if the proposed DNA sequencing scheme is to be viable.
    DOI:
    10.1002/(sici)1521-3765(19990301)5:3<951::aid-chem951>3.0.co;2-g
  • 作为产物:
    描述:
    [5-(4-Formyl-2-methoxy-5-nitro-phenoxy)-pentyl]-carbamic acid allyl ester 在 四(三苯基膦)钯 4-二甲氨基吡啶sodium hydroxide 、 sodium tetrahydroborate 、 四溴化碳四丁基氢氧化铵二乙胺三乙胺三苯基膦 、 sodium iodide 作用下, 以 四氢呋喃乙醇氯仿乙酸乙酯N,N-二甲基甲酰胺 为溶剂, 反应 36.5h, 生成 3'-O-<4''-((N-dansyl)-5'''-aminopent-1-yl-oxy)-5''-methoxy-2''nitrophenylmethyl>-2'-deoxy-5'-O-(tert-butyldiphenylsilyl)-N-6-benzoyladenosine
    参考文献:
    名称:
    Syntheses of Nucleosides Designed for Combinatorial DNA Sequencing
    摘要:
    Nucleoside triphosphates I with 3'-O-blocking groups that are both photolabile and fluorescent were required to investigate the viability of a strategy for sequencing DNA in a combinatorial fashion (see Figure 1). Four compounds were prepared to realize this goal. Two of them, 14a and 14t, had dansyl-functionalized, 3'-O-(2"-nitrobenzyl) ether groups, while the other two, 18a and 18t, had similar pendant carbonate groups. Tests for incorporation of these analogues were performed by using five different DNA replicating enzymes, but the analogues were not incorporated. These results were surprising in view of the fact that previous studies had shown that 3'-O-(2"-nitrobenzyl)adenosine triphosphate II was incorporated by Bst DNA polymerase I. However, molecular simulations with the coordinates of a T7 polymerase crystal structure as a model demonstrates that analogues 14a, 14t, 18a and 18t are too large to fit into the enzyme active site, whereas accommodation of the unsubstituted 2-nitrobenzyl compound II is much less demanding. We conclude that both the nucleoside triphosphates and the DNA polymerase enzyme must be modified if the proposed DNA sequencing scheme is to be viable.
    DOI:
    10.1002/(sici)1521-3765(19990301)5:3<951::aid-chem951>3.0.co;2-g
点击查看最新优质反应信息

同类化合物

鸟苷酰-3'-5'-胞苷铵盐 鸟苷酰-(3'-5')-尿苷 鸟苷酰(3'-5')尿苷3'-单磷酸酯 腺苷酰基-(3,’5’)-胞苷 腺苷酰-(3'→5')-胞苷 腺苷酰-(3'-5')-尿苷3'-单磷酸酯 腺苷基3'-5'-腺苷铵盐 脱氧鸟苷酰-(3'-5')-鸟苷 脱氧鸟苷酰-(3'-5')-脱氧腺苷 脱氧腺苷酰-(3'-5')-脱氧鸟苷 脱氧胞苷酰-(3'-5')-脱氧鸟苷 胸苷酰-(3'-5')脱氧尿苷 胸苷酰-(3'-5')-3'-胸苷酸 胸苷酰-(3'-5')-2'-脱氧-5-氟尿苷 胸苷酰(3'->5')胸苷铵盐 胸苷基(3'5')-2'-脱氧腺苷铵盐 胞苷酰-(5'->3')-鸟苷 胞苷酰-(3',5')-鸟苷 胞苷酰(3'->5')尿苷铵盐 聚(2-氨基脱氧腺嘌呤基-5-碘脱氧尿苷酸) 聚(2-氨基脱氧腺嘌呤基-5-溴脱氧尿苷酸) 环二腺苷酸 尿酸氧化酶 尿苷酰基-(3',5')-尿苷 二(3',5')-环二鸟苷酸 乙基3,4,5-三[[(6-重氮基-5,6-二氢-5-羰基-1-萘基)磺基基]氧代]苯酸酯 [5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基][5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [5-(6-氨基嘌呤-9-基)-3,4-二羟基-四氢呋喃-2-基]甲基[羟基-[2,3,4-三羟基-5-(7-甲基-2,4,8-三氧代-1H-嘧啶并[4,5-b]喹啉-10-基)戊氧基]磷酰]磷酸氢酯 [5-(4-氨基-2-氧代-嘧啶-1-基)-3,4-二羟基-四氢呋喃-2-基]甲基[5-(4-氨基-2-氧代-嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(6-氨基嘌呤-9-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,5R)-5-(2,4-二氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基 [(2R,3S,5R)-2-(羟基甲基)-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2,4-二氧代嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 N-羟基联苯基-4,4'-二胺 N-{1-[(2-氨基乙基)硫烷基]丙烷-2-基}-6-甲氧基-4-甲基-5-[3-(三氟甲基)苯氧基]喹啉-8-胺 8-氯-黄素腺嘌呤二核苷酸 8-巯基-黄素腺嘌呤二核苷酸 5-脱氮黄素腺嘌呤二核苷酸 5'-磷酰胸苷酰(3'-5')脱氧腺苷 5'-O-胸苷酰 3'-O-(2'-脱氧腺苷)硫代磷酸酯 2'-脱氧鸟苷酰-(5'-3')-2'-脱氧-5'-鸟苷酸 2'-脱氧鸟苷酰-(3'-5')-2'-脱氧胞苷 2'-脱氧鸟苷酰(3'->5')-2'-脱氧鸟苷钠盐 2'-脱氧腺苷酰-(3'-5')-2'-脱氧腺苷 2'-脱氧胞苷酰-(3'-5')-胸苷 2'-脱氧胞啶基(3'->5')-2'-脱氧鸟苷铵盐 1H-苯并三唑,硫酸酯(1:1) 1-(2-脱氧-5-O-磷羧基五呋喃糖基)-5-[(1E)-3-{[5-(2-羰基六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰基]氨基}丙-1-烯-1-基]嘧啶-2,4(1H,3H)-二酮